Telix Pharmaceuticals | TLX - Ebitda

Preço das Ações
12.75
Mudança Diária
0.34 2.74%
Mensal
32.67%
Anual
-54.43%
Q1 Previsão
12.48




Ebitda Alterar Data
Cochlear AUD 306.4M 13.5M 2025-12
CSL USD 3.13B 1.17B 2025-12
Integral Diagnostics AUD 46.27M 3.52M 2024-06
Mayne Pharma AUD 20.9M 5.2M 2025-06
Medical Developments International AUD 1.78M 3.78M 2024-12
Mesoblast USD -20.3M 2.51M 2025-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Pacific Edge NZD -13.97M 332K 2024-09
Paradigm Biopharmaceuticals AUD -5.86M 3.79M 2024-12
Polynovo AUD 3.89M 100K 2025-12
PYC Therapeutics AUD -22.79M 1.5M 2025-12
Ramsay Health Care AUD 1.12B 10.6M 2025-12
ResMed USD 547.48M 27.46M 2025-12
Sonic Healthcare AUD 839.07M 51.09M 2024-12